Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03550131 · ClinicalTrials.gov registry record · NA
Innovations in Dementia Empowerment and Action
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 322
- Enrollment target
NCT03550131 is a NA study that has completed, run by University of Washington. The registered enrollment target is 322 participants.
The verdict
NCT03550131, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 322 participants
- Enrollment target
Study Summary
The lack of efficacious research-based interventions for such vulnerable older adults with Alzheimer's disease and related dementias (AD/RD) and their caregivers (CGs) is a significant public health problem. Caregiving of sexual/gender minority older adults with AD/RD is of concern due to social stigma, marginalization, and isolation, which may be barriers to sustaining caregiving. It is necessary and timely to translate evidence-based culturally adaptable interventions for this underserved and stigmatized population. Reducing Disability in Alzheimer's Disease (RDAD) has been evaluated in a randomized controlled trial and has shown to successfully train community-dwelling CR (care receiver)-CG dyads to increase the physical activity and functioning of individuals with AD/RD and their CGs and to teach CGs techniques for managing behavioral symptoms of CRs. RDAD consequently decreases stress of CGs, delays institutionalization of CRs, and increases health related quality of life (HRQOL) of CRs and CGs. Thus, this study will evaluate the effect of the standard RDAD among lesbian, gay, bisexual, and transgender (LGBT) CRs with AD/RD and their CGs, and this study will test a personalized intervention tailored to better respond to distinct risks experienced by CGs and LGBT CRs with AD/RD, addressing unique sexual/gender minority CG risk factors (e.g., identity management, stigma-related adverse or traumatic life events, and lack of social support).
Interventions
- BEHAVIORAL Innovations in Dementia Empowerment and Action (IDEA)
- BEHAVIORAL Reducing Disabilities in Alzheimer's Disease (RDAD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 322 participants |
| Start Date | 2018-12-05 |
| Est. Completion | 2023-05-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03550131
The ClinicalTrials.gov registry entry for NCT03550131 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 322 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Innovations in Dementia Empowerment and Action (IDEA) is the first listed.
NCT03550131 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03550131 about?
NCT03550131 is a clinical study titled "Innovations in Dementia Empowerment and Action". The lack of efficacious research-based interventions for such vulnerable older adults with Alzheimer's disease and related dementias (AD/RD) and their caregivers (CGs) is a significant public health problem. Caregiving of sexual/gender minority older adults with AD/RD is of concern due to social sti...
What is the current status of trial NCT03550131?
This trial is currently completed. It is a NA study. The enrollment target is 322 participants. The study started on 2018-12-05. Estimated completion is 2023-05-16.
What interventions are being tested in trial NCT03550131?
The interventions under investigation include: Innovations in Dementia Empowerment and Action (IDEA) (BEHAVIORAL), Reducing Disabilities in Alzheimer's Disease (RDAD) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03550131?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.